Skip to content

A Culturally Sensitive Social Support Intervention

A Culturally Sensitive Social Support Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02946697
Acronym
JLA
Enrollment
168
Registered
2016-10-27
Start date
2015-01-31
Completion date
2024-10-14
Last updated
2024-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Breast Neoplasms

Keywords

Chinese, cancer survivors, Quality of Life, Social Support

Brief summary

This study is a randomized controlled trial (RCT) to assess the impact of a culturally based social support program (i.e. Joy Luck Academy, JLA) among Chinese American breast cancer survivors.

Detailed description

This study is a randomized controlled trial (RCT) to test the health benefits of an education and peer mentor support intervention. Chinese American breast cancer survivors who have completed primary treatment will be randomly assigned to either the intervention group or a control group to receive enhanced usual care while waiting for the JLA. Health outcomes are assessed at baseline, immediately post intervention, and 1 and 4 months follow-ups.

Interventions

The social support intervention is a 7-week program includes educational and peer mentoring support components. The education curriculum provides information on recognizing side effects of treatment and differentiating them from symptoms of cancer recurrence, physical therapy and alternative treatment, stress management, recognizing depression and managing emotional problems, communication with family members, and body image. The peer-support component assigns each participant with a mentor who is a breast cancer survivor. They share their own experience with participants and also make weekly phone calls to mentees during the intervention to provide support and address remaining concerns.

Sponsors

University of California, Los Angeles
CollaboratorOTHER
Herald Cancer Association
CollaboratorOTHER
National Cancer Institute (NCI)
CollaboratorNIH
M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* self-identified to be comfortable speaking Chinese (Mandarin or Cantonese) * having a first breast cancer diagnosis of stages 0-III * having completed primary treatment (surgery, chemotherapy, or radiotherapy) within the last 36 months

Exclusion criteria

* unable to read or speak Chinese (Mandarin or Cantonese) * breast cancer diagnosis of stage IV * live outside of the LA area

Design outcomes

Primary

MeasureTime frame
Change in Quality of life as assessed by Functional Assessment of Cancer Therapy Scale (FACT)Baseline before intervention and immediately, 1 month, and 4 months after the intervention

Secondary

MeasureTime frameDescription
Change in depressive symptoms as assessed by CES-DBaseline before intervention and immediately, 1 month, and 4 months after the interventionDepressive symptoms will be measured with the Chinese short-form version (Boey, 1999) of the Center for Epidemiologic Studies Depression Scale (CES-D; Radloff, 1977) as well as two additional items (I don't want to have contact with people, socialize, or go out at all and I have thought about hurting myself) from the Chinese American Depression Scale (CADS-9).
Change in positive affect as assessed by the PANASBaseline before intervention and immediately, 1 month, and 4 months after the intervention
Change in fatigue as assessed by FACITBaseline before intervention and immediately, 1 month, and 4 months after the interventionA short-version (i.e. 6-item) of Functional Assessment of Chronic Illness Therapy-Fatigue scale was used.
Change in stress as assessed by the Perceived stress scale (PSS)Baseline before intervention and immediately, 1 month, and 4 months after the intervention

Other

MeasureTime frame
Change in cortisol slopeBaseline before intervention and immediately

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026